Accendra Health, Inc.
ACH
$2.04
$0.084.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -203.47% | -2,647.58% | -2,734.35% | -843.49% | -778.15% |
| Total Depreciation and Amortization | 18.34% | -34.59% | -38.48% | -38.68% | -33.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.51% | 5,345.23% | 3,764.80% | 1,052.22% | 1,320.75% |
| Change in Net Operating Assets | 188.53% | -3,268.04% | -69.93% | -87.90% | -95.66% |
| Cash from Operations | -163.03% | -148.93% | -69.66% | -66.11% | -78.20% |
| Capital Expenditure | -12.14% | -0.83% | -7.95% | 5.63% | 10.78% |
| Sale of Property, Plant, and Equipment | 11.50% | -62.47% | -63.15% | -64.09% | -2.30% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -313.34% | -323.10% | 34.64% | -11.76% | 9.94% |
| Cash from Investing | 223.93% | -87.01% | -66.27% | -55.20% | 15.10% |
| Total Debt Issued | 38.69% | 153.24% | 285.42% | 495.59% | 341.51% |
| Total Debt Repaid | -15.58% | -95.03% | -201.11% | -322.48% | -162.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.60% | 326.45% | -237.57% | -454.51% | -3,574.41% |
| Cash from Financing | 170.28% | 195.20% | 54.38% | 3.54% | 35.88% |
| Foreign Exchange rate Adjustments | 310.43% | -70.18% | 696.98% | 189.62% | -246.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 204.06% | 83.48% | -451.11% | -212.66% | -219.71% |